Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro

被引:51
作者
Sun, Wei-Hao [1 ]
Zhu, Feng [2 ]
Chen, Guo-Sheng [1 ]
Su, Han [3 ]
Luo, Cheng [4 ,5 ]
Zhao, Qin-Shi [4 ]
Zhang, Yuan [1 ]
Shao, Yun [1 ]
Sun, Jian [6 ]
Zhou, Su-Ming [1 ]
Ding, Guo-Xian [1 ]
Cheng, Yun-Lin [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing 210029, Jiangsu, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Shanghai 200080, Peoples R China
[3] Govt Off Hosp Jiangsu Prov Peoples Govt, Dept Med, Nanjing 210024, Jiangsu, Peoples R China
[4] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Peoples R China
[5] Univ Turku, Inst Biomed, FIN-20520 Turku, Finland
[6] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China
关键词
cholecystokinin-2; receptor; cyclooxygenase-2; MKN-45; cell; proliferation; apoptosis;
D O I
10.1016/j.canlet.2008.01.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastrin and cyclooxygenase-2 (COX-2) play important roles in the carcinogenesis and progression of gastric cancer. However, it remains unknown whether the combination of cholecystokinin-2 (CCK-2) receptor antagonist plus COX-2 inhibitor exerts synergistic anti-tumor effects on human gastric cancer. Here, we demonstrated that the combination of AG-041R (a CCK-2 receptor antagonist) plus NS-398 (a selective COX-2 inhibitor) treatment had synergistic effects on proliferation inhibition, apoptosis induction, down-regulation of Bcl-2 and up-regulation of Bax expression in MKN-45 cells. These results indicate that simultaneous targeting of CCK-2 receptor and COX-2 may inhibit gastric cancer development more effectively than targeting either molecule alone. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:302 / 311
页数:10
相关论文
共 40 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Regulation of apoptosis by Bcl-2 family proteins [J].
Burlacu, A .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) :249-257
[3]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[4]   Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth [J].
Hellmich, MR ;
Rui, XL ;
Hellmich, HL ;
Fleming, RYD ;
Evers, BM ;
Townsend, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :32122-32128
[5]  
Honjo S, 2005, INT J ONCOL, V26, P353
[6]   A semiempirical free energy force field with charge-based desolvation [J].
Huey, Ruth ;
Morris, Garrett M. ;
Olson, Arthur J. ;
Goodsell, David S. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2007, 28 (06) :1145-1152
[7]   Expression of gastrin and its receptor in human gastric cancer tissues [J].
Hur, K ;
Kwak, MK ;
Lee, HJ ;
Park, DJ ;
Lee, H ;
Lee, HS ;
Kim, WH ;
Michaeli, D ;
Yang, HK .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (02) :85-91
[8]   THE EFFECT OF GASTRIN ON GROWTH OF HUMAN STOMACH-CANCER CELLS [J].
ISHIZUKA, J ;
MARTINEZ, J ;
TOWNSEND, CM ;
THOMPSON, JC .
ANNALS OF SURGERY, 1992, 215 (05) :528-535
[9]   Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats [J].
Komori, M ;
Tsuji, S ;
Sun, WH ;
Tsujii, M ;
Kawai, N ;
Yasumaru, M ;
Kakiuchi, Y ;
Kimura, A ;
Sasaki, Y ;
Higashiyama, S ;
Kawano, S ;
Hori, M .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (06) :G1368-G1378
[10]  
Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P857